Sanofi buys an mRNA startup in another bet on 'off-the-shelf' cell therapy
Bio Pharma Dive
APRIL 9, 2021
Tidal Therapeutics is the second biotech developing more convenient cell therapies that the French pharma has recently acquired, part of a broader expansion in oncology.
Let's personalize your content